Table 1.
Baseline characteristics of participants
| Variables | Values |
|---|---|
| Age (years), median (IQR) | 68 (61–72) |
| Male (%) | 91.7 |
| Smoking (%) | |
| Never | 8.3 |
| Ever | 91.7 |
| ECOG PS (%) | |
| 0 | 41.7 |
| 1 | 58.3 |
| Pathology (%) | |
| Non‐small cell lung cancer | 83.3 |
| Small cell lung cancer | 16.7 |
| Stage (%) | |
| IIIB | 8.3 |
| IV | 75.0 |
| Extensive disease | 16.7 |
| Six‐minute walk distance (m) | 426 (375–449) |
| Pulmonary function test | |
| FVC (L) | 2.93 (2.85–3.56) |
| FVC pred. (%) | 81.5 (73.5–87.0) |
| FEV1 (L) | 2.24 (1.77–2.50) |
| FEV1 pred. (%) | 82.5 (60.0–86.5) |
| FEV1/FVC | 71.0 (65.5–77.0) |
| CPET | |
| Work (watts) | 60.5 (52.5–77.0) |
| Work pred. (%) | 42.5 (34.5–61.0) |
| VO2 max (mL/kg/minutes) | 20.4 (16.7–23.1) |
| VO2 max pred. (%) | 79.0 (72.5–99.0) |
| AT (% pred. Max VO2) | 42 (33–48) |
Values are presented median (IRQ)
AT, anaerobic threshold; CPET, cardiopulmonary exercise test; ECOG PS, Eastern Cooperative Oncology Group performance status; FVC, forced vital capacity; FEV1, forced expiratory volume in one second; IQR, interquartile range; VO2, maximal oxygen consumption.